Patient Considerations in the Management of Chronic Constipation: Focus on Prucalopride

Patient Preference and Adherence - New Zealand
doi 10.2147/ppa.s92550
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Prucalopride: Novel Drug for Chronic Idiopathic Constipation

International Journal of Basic & Clinical Pharmacology
2019English

Chronic Constipation: Update on Management

Cleveland Clinic Journal of Medicine
Medicine
2017English

Role of Prucalopride, a Serotonin (5-Ht4) Receptor Agonist, for the Treatment of Chronic Constipation

Clinical and Experimental Gastroenterology
Gastroenterology
2010English

Management of Chronic Constipation in Adults

United European Gastroenterology Journal
OncologyGastroenterology
2016English

Prucalopride Improves Bowel Function and Colonic Transit Time in Patients With Chronic Constipation: An Integrated Analysis

American Journal of Gastroenterology
HepatologyGastroenterology
2014English

Efficacy and Safety of Oral Prucalopride in Women With Chronic Constipation in Whom Laxatives Have Failed: An Integrated Analysis

United European Gastroenterology Journal
OncologyGastroenterology
2013English

Patient Considerations in the Treatment of COPD: Focus on the New Combination Inhaler Umeclidinium/Vilanterol

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2015English

Confirmatory Factor Analysis of the Patient Assessment of Constipation-Symptoms (PAC-SYM) Among Patients With Chronic Constipation

Quality of Life Research
EnvironmentalPublic HealthOccupational Health
2014English

Investigation and Management of Long-Standing Chronic Constipation in Childhood.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1976English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy